DK101791C - Fremgangsmåde til fremstilling af kulhydratderivater af 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin. - Google Patents

Fremgangsmåde til fremstilling af kulhydratderivater af 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin.

Info

Publication number
DK101791C
DK101791C DK181262AA DK181262A DK101791C DK 101791 C DK101791 C DK 101791C DK 181262A A DK181262A A DK 181262AA DK 181262 A DK181262 A DK 181262A DK 101791 C DK101791 C DK 101791C
Authority
DK
Denmark
Prior art keywords
pyrazolidine
dioxo
diphenyl
butyl
preparation
Prior art date
Application number
DK181262AA
Other languages
Danish (da)
English (en)
Original Assignee
Purdue Frederick Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Frederick Co filed Critical Purdue Frederick Co
Application granted granted Critical
Publication of DK101791C publication Critical patent/DK101791C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Drying Of Solid Materials (AREA)
DK181262AA 1961-04-24 1962-04-18 Fremgangsmåde til fremstilling af kulhydratderivater af 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin. DK101791C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12179661A 1961-04-24 1961-04-24

Publications (1)

Publication Number Publication Date
DK101791C true DK101791C (da) 1965-05-31

Family

ID=22398845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK181262AA DK101791C (da) 1961-04-24 1962-04-18 Fremgangsmåde til fremstilling af kulhydratderivater af 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin.

Country Status (6)

Country Link
BR (1) BR6238369D0 (pt)
DE (1) DE1470148A1 (pt)
DK (1) DK101791C (pt)
FI (2) FI43993B (pt)
GB (1) GB1002649A (pt)
NO (1) NO117481B (pt)

Also Published As

Publication number Publication date
DE1470148A1 (de) 1969-06-04
BR6238369D0 (pt) 1973-05-10
FI48735B (pt) 1974-09-02
NO117481B (pt) 1969-08-18
FI48735C (fi) 1974-12-10
GB1002649A (en) 1965-08-25
FI43993B (pt) 1971-04-30

Similar Documents

Publication Publication Date Title
DK119005B (da) Fremgangsmåde til fremstilling af 3-alkoxy-13-alkylgona-1,3,5(10),8,14-penten-17-oner.
DK114058B (da) Fremgangsmåde til fremstilling af 2,4-disulfamyl-N-(3-hydroxy-2-propenyliden)-anilinderivater.
DK108971C (da) Fremgangsmåde til fremstilling af 6,17α -dimethylprogesteronderivater.
DK116219B (da) Fremgangsmåde til fremstilling af 1,2,4-triazoler.
DK112306B (da) Fremgangsmåde til fremstilling af 2,6-dichlor-toluenderivater.
DK103396C (da) Fremgangsmåde til fremstilling af estere af 17α-ethynyl-5(10)-estren-3β,17β-diol.
DK101791C (da) Fremgangsmåde til fremstilling af kulhydratderivater af 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin.
DK109145C (da) Fremgangsmåde til fremstilling af 3,5-dioxo-1,2,4-triazolidiner eller salte deraf.
DK116280B (da) Fremgangsmåde til fremstilling af 4,5-dehydro-3-keto-19-nor-steroider.
FI45046C (fi) Menetelmä rauhoittavina aineina vaikuttavien fentiatsiinien 3,8-diatsa bisyklo-oktaani-johdannaisten valmistamiseksi.
DK102964C (da) Fremgangsmåde til fremstilling af 4-oxo-6-sulfamyl-1,2,3,4-tetrahyrdoquinazolinonderivater.
DK99013C (da) Fremgangsmåde til fremstilling af 6,16-dimethyl-1,4,15-pregnatrienderivater.
DK105033C (da) Fremgangsmåde til fremstilling af D-6-methyl- eller 1,6-dimethyl-8-aminomethylergolin-N-acylderivater.
DK98242C (da) Fremgangsmåde til fremstilling af 6,16-dimethyl-17α-hydroxy-3,20-diketo-4,6,15-pregnatrienderivater.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.
DK111175B (da) Fremgangsmåde til fremstilling af 4',19-diacylcymaroler.
DK127327B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydronaphthalen-2-on-derivater.
DK103025C (da) Fremgangsmåde til fremstilling af 1,4-dioxanderivater.
DK119108B (da) Fremgangsmåde til fremstilling af C-D-trans-3-hydroxy-13-alkyl-17-oxogona-1,3,5(10),6,8-pentener.
DK125088B (da) Fremgangsmåde til fremstilling af 8-hydroxy-13-alkylgona-1,3,5(10),9(11)-tetraener.
DK98885C (da) Fremgangsmåde til fremstilling af 18,19-dinor-13-β-n-propyl-17α-ethinyl-testosteron.
DK115333B (da) Fremgangsmåde til fremstilling af 3,5-dioxopyrazolidinderivater.
DK103671C (da) Fremgangsmåde til fremstilling af 2,2'4,4'-tetrabrom-N-alkyl-diphenylaminer.
DK101064C (da) Fremgangsmåde til fremstilling af 3,5-dioxo-1,2,4-triazolidiner eller salte deraf.